In the latest trading session, 1.87 million DarioHealth Corp (NASDAQ:DRIO) shares changed hands as the company’s beta touched 1.51. With the company’s most recent per share price at $0.70 changing hands around $0.02 or 2.81% at last look, the market valuation stands at $29.05M. DRIO’s current price is a discount, trading about -175.71% off its 52-week high of $1.93. The share price had its 52-week low at $0.56, which suggests the last value was 20.0% up since then. When we look at DarioHealth Corp’s average trading volume, we note the 10-day average is 0.18 million shares, with the 3-month average coming to 740.25K.
Analysts gave the DarioHealth Corp (DRIO) stock a consensus recommendation rating of Buy, calculated at a mean rating of 2.00. If we narrow down to specifics, the data shows that 0 out of 3 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended DRIO as a Hold, 3 felt it is a Buy and 0 rated the stock as Underweight. DarioHealth Corp’s EPS for the current quarter is expected to be -0.05.
DarioHealth Corp (NASDAQ:DRIO) trade information
Instantly DRIO is in green as seen in intraday trades today. With action 10.93%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -11.08%, with the 5-day performance at 10.93% in the green. However, in the 30-day time frame, DarioHealth Corp (NASDAQ:DRIO) is -3.05% down. Looking at the short shares, we see there were 2.58 million shares sold at short interest cover period of 4.77 days.
The consensus price target for the stock as assigned by Wall Street analysts is 10.75, meaning bulls need an upside of 93.49% from its recent market value. According to analyst projections, DRIO’s forecast low is 7.5 with 14 as the target high. To hit the forecast high, the stock’s price needs a -1900.0% plunge from its current level, while the stock would need to soar -971.43% for it to hit the projected low.
DarioHealth Corp (DRIO) estimates and forecasts
Year-over-year growth is forecast to reach 20.01% up from the last financial year.
Consensus estimates given by 2 financial analysts project the company’s revenue in the current quarter to hit an average of 7.47M. 2 analysts are of the opinion that DarioHealth Corp’s revenue for the current quarter will be 7.76M. The company’s revenue for the corresponding quarters a year ago was 5.76M and 6.25M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 29.81%. The estimates for the next quarter sales put growth at 24.08%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 41.84%. The 2025 estimates are for DarioHealth Corp earnings to increase by 62.30%, but the outlook for the next 5-year period is at 56.56% per year.
DarioHealth Corp (NASDAQ:DRIO)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 21.28% of DarioHealth Corp shares while 20.20% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 25.66%. There are 20.20% institutions holding the DarioHealth Corp stock share, with NANTAHALA CAPITAL MANAGEMENT, LLC the top institutional holder. As of 2024-06-30, the company held 6.9429% of the shares, roughly 2.39 million DRIO shares worth $2.85 million.
APPIAN WAY ASSET MANAGEMENT LP holds the second largest percentage of outstanding shares, with 3.9947% or 1.38 million shares worth $1.64 million as of 2024-06-30.
Among Mutual Funds, the top two as of Dec 31, 2024 were Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund. With 355.61 shares estimated at $0.24 million under it, the former controlled 0.86% of total outstanding shares. On the other hand, Fidelity Extended Market Index Fund held about 0.36% of the shares, roughly 149.24 shares worth around $0.1 million.
